ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

Provenge Met Criteria For Approval, Sponsor Says

May 1, 2009

CT Scanning Use, Costs, Controls Debated By NCAB

October 7, 1977

Research Needed To Improve Survival In Adolescents, Young Adults With Cancer

January 26, 2007

NCAB Okays New System For Bypass Budget; FY 1983 Request $1.096 Billion DCCP Board Approves Payback System For Resources Now Free

June 5, 1981

NAS Committee Urges Greater Rewards For Interdisciplinary Research.

January 21, 2005